Oseltamivir Market - Forecast 2020 - 2025
Oseltamivir Market size is forecast to reach $694.3 million by 2025, growing at a CAGR of 3.17% during the forecast period 2020-2025. Oseltamivir, sold under the brand name Tamiflu, is an antiviral medication used to treat and prevent influenza A and influenza B. Many medical organizations recommend it in people who have complications or are at high risk of complications within 48 hours of first symptoms of infection. It helps make the symptoms like stuffy nose, cough, sore throat, fever/chills, aches, and tiredness less severe and shortens the recovery time by 1-2 days. Oseltamivir acts as neuraminidase inhibitor of the influenza virus, by preventing its reproduction by budding from the host cell. This also prevents the cleavage of sialic acid residues, thus interfering with progeny virus disbursement within the mucosal secretions and reducing viral infectivity. Growing incidences of influenza among the population, increasing awareness about the prevention, and increasing investments...